Lipid-polymer based complexation and delivery of nucleic acids
US-11434317-B2 · Sep 6, 2022 · US
US12344693B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12344693-B2 |
| Application number | US-202217892637-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 22, 2022 |
| Priority date | Apr 16, 2019 |
| Publication date | Jul 1, 2025 |
| Grant date | Jul 1, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides novel polymers, crosslinked polymer-nucleic acid complexes, lipid-polymer-nucleic acid-based complexation and nanoassemblies, and nanoassembly-based intracellular delivery of nucleic acids and controlled release thereof upon degradation of the nanoassemblies in response to specific microenvironment in the cell, and compositions and methods of preparation and use thereof.
Opening claim text (preview).
The invention claimed is: 1. A molecular assembly, comprising: a crosslinked polymer-nucleic acid complex comprising a nucleic acid encapsulated in a crosslinked polymer network; and a coating on the crosslinked polymer-nucleic acid complex, wherein the coating comprises a zwitterionic lipid and a PEGylated lipid. 2. The molecular assembly of claim 1 , wherein the crosslinked polymer-nucleic acid complex comprises: a crosslinked block or random copolymer comprising structural units of: wherein each of R 1 and R′ 1 is independently a hydrogen, C 1 -C 12 alkyl group, or halogen; each of R 2 , R′ 2 , R 3 , and R′ 3 is independently a hydrogen, C 1 -C 16 alkyl, C 1 -C 16 alkyloxy, or halogen; each of L 1 and L 2 is independently a linking group; each of S 1 and S 2 is independently a single bond or a spacer group; W is a hydrophobic group; and X is a group comprising a crosslinking moiety; and a nucleic acid molecule entrapped in the crosslinked block or random copolymer. 3. The molecular assembly of claim 2 , wherein the block or random copolymer further comprises the structural unit of: wherein R″ 1 is a hydrogen, C 1 -C 12 alkyl group, or halogen; each of R″ 2 and R″ 3 is independently a hydrogen, C 1 -C 16 alkyl, C 1 -C 16 alkyloxy, or halogen; L 3 is a linking group; S 3 is a single bond or a spacer group; and Y is a non-crosslinking group. 4. The molecular assembly of claim 2 , wherein X comprises a crosslinked group. 5. The molecular assembly of claim 2 , wherein X comprises a group capable of forming a crosslinking bond. 6. The molecular assembly of claim 2 , wherein the nucleic acid molecule is selected from single-standed or double-stranded RNA or DNA, and derivatives or anologs thereof. 7. The molecular assembly of claim 2 , wherein the nucleic acid molecule is selected from dsRNA, siRNA, mRNA, ncRNA, microRNA, catalytic RNA, gRNA, DNAs, oligonucleotides, aptamers, genes, plasmids, and derivatives or anologs thereof. 8. The molecular assembly of claim 7 , wherein the nucleic acid molecule is an siRNA. 9. The molecular assembly of claim 2 , wherein the copolymer is a random copolymer. 10. The molecular assembly of claim 2 , wherein the copolymer is a block copolymer. 11. The molecular assembly of claim 2 , wherein W comprises a C 1 -C 30 linear or branched alkyl group. 12. The molecular assembly of claim 2 , wherein each of L 1 , L 2 and L 3 is independently a group. 13. The molecular assembly of claim 2 , wherein X comprises a disulfide group. 14. The molecular assembly of claim 2 , wherein the block or random copolymer further comprises the structural unit of: wherein X′ comprises a group selected from: wherein R is a C 1 -C 15 alkyl group, and Z is a counter ion. 15. The molecular assembly of claim 2 , being crosslinked both inter-molecularly and intra-molecularly. 16. The molecular assembly of claim 2 , wherein the zwitterionic lipid comprises a zwitterionic group selected from the group consisting of: wherein each R is hydrogen or a C 1 -C 15 alkyl group; n is independently an integer from about 1 to about 12. 17. The molecular assembly of claim 16 , wherein each n is independently an integer from about 2 to about 6.
Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine · CPC title
obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin · CPC title
Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery · CPC title
and containing nitrogen · CPC title
Use of a di- or tri-thiocarbonylthio compound, e.g. di- or tri-thioester, di- or tri-thiocarbamate, or a xanthate as chain transfer agent, e.g . Reversible Addition Fragmentation chain Transfer [RAFT] or Macromolecular Design via Interchange of Xanthates [MADIX] · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.